Impact of expression of the uPA system in sarcomas (Q38111811)

29 August 2017

title

Impact of expression of the uPA system in sarcomas (English)

1 reference

29 August 2017

Helge Taubert

0 references

Viktor Magdolen

1 reference

29 August 2017

Matthias Kotzsch

1 reference

29 August 2017

publication date

1 June 2013

1 reference

29 August 2017

published in

Biomarkers in Medicine

1 reference

29 August 2017

1 reference

29 August 2017

1 reference

29 August 2017

page(s)

473-480

1 reference

Activity-based protein profiling implicates urokinase activation as a key step in human fibrosarcoma intravasation

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.105

uPAR mediates anticancer activity of PEDF.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.105

Structure-based design of an urokinase-type plasminogen activator receptor-derived peptide inhibiting cell migration and lung metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.105

Involvement of the soluble urokinase receptor in chondrosarcoma cell mobilization

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.105

Pathology of soft tissue sarcomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.105

Sarcoma derived from cultured mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.105

A review of clinical and molecular prognostic factors in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.105

Recent advances in the molecular pathology of soft tissue sarcoma: implications for diagnosis, patient prognosis, and molecular target therapy in the future

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.105

Co-expression of survivin and TERT and risk of tumour-related death in patients with soft-tissue sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.105

Sarcoma spreads primarily through the vascular system: are there biomarkers associated with vascular spread?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.105

[Sarcoma gene signatures].

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.105

Gene expression identifies heterogeneity of metastatic propensity in high-grade soft tissue sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.105

Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.105

The urokinase plasminogen activator system: a rich source of tumour markers for the individualised management of patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.105

Evolving role of uPA/uPAR system in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.105

Cancer invasion and metastasis: changing views.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.105

The plasminogen activator system and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.105

Clinical utility of level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.105

The urokinase plasminogen activator system: role in malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.105

Characteristics of the level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.105

Structure of human urokinase plasminogen activator in complex with its receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.105

Intact and cleaved uPAR forms: diagnostic and prognostic value in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.105

Proteolytic regulation of the urokinase receptor/CD87 on monocytic cells by neutrophil elastase and cathepsin G

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.105

Characterisation of urokinase plasminogen activator receptor variants in human airway and peripheral cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.105

Regulation of cell signalling by uPAR.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.105

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.105

A new look at node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.105

Clinical significance of urokinase-type plasminogen activator receptor (uPAR) expression in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.105

Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.105

Elevated urinary levels of urokinase-type plasminogen activator receptor (uPAR) in pancreatic ductal adenocarcinoma identify a clinically high-risk group.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.105

Prognostic impact of liberated domain I of the urokinase plasminogen activator receptor in squamous cell lung cancer tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.105

Combined mRNA expression levels of members of the urokinase plasminogen activator (uPA) system correlate with disease-associated survival of soft-tissue sarcoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.105

Co-detection of members of the urokinase plasminogen activator system in tumour tissue and serum correlates with a poor prognosis for soft-tissue sarcoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.105

UPA and PAI-1 analysis from fixed tissues - new perspectives for a known set of predictive markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.12.105

21 January 2018

Identifiers

DOI

10.2217/BMM.12.105

1 reference

29 August 2017

1 reference